Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancer Management and Research|August 21, 2012
Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanomaRosalie Fisher, James Larkin
The New Zealand Medical Journal|August 19, 2016
Subsidised access to new melanoma drugs: in need of further innovation?Michael Wonder, Rosalie Fisher
Expert Opinion on Investigational Drugs|April 22, 2011
New targeted therapies for renal cell carcinomaRosalie Fisher, Lisa Pickering, James Larkin
Seminars in Cancer Biology|June 19, 2012
Current and future systemic treatments for renal cell carcinomaRosalie Fisher, Martin Gore, James Larkin
The EPMA Journal|June 29, 2012
Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneityRosalie Fisher, James Larkin, Charles Swanton
Therapeutic Advances in Medical Oncology|March 2, 2013
Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigmMuhammad Khattak, Rosalie Fisher, Samra Turajlic, et al.
Melanoma Research|December 6, 2012
Ipilimumab activity in advanced uveal melanomaMuhammad Adnan Khattak, Rosalie Fisher, Peta Hughes, et al.
Breast (Edinburgh, Scotland)|November 13, 2013
Primary and secondary distant metastatic breast cancer: two sides of the same coinUwe Güth, Isotta Magaton, Dorothy Jane Huang, et al.
Radiology|May 30, 2014
Revised Choi imaging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinibYeeliang Thian, Andreas Gutzeit, Dow-Mu Koh, et al.
Melanoma Research|December 20, 2015
Prognostic markers and tumour growth kinetics in melanoma patients progressing on vemurafenibHeike Seifert, Rosalie Fisher, Juan Martin-Liberal, et al.
Pageof 3